Breaking News

Harbour BioMed Establishes Wholly-Owned Subsidiary, Nona Biosciences

Subsidiary will make Harbour’s technologies broadly accessible to biotechnology and biopharma companies and academic institutions.

Author Image

By: Charlie Sternberg

Associate Editor

Harbour BioMed has established a wholly-owned subsidiary, Nona Biosciences, to provide next-generation antibody and biotherapeutic solutions to partners from discovery to IND.   The new subsidiary will leverage Harbour BioMed’s technology platforms, including its Harbour Mice and HBICE for fully human antibody generation, and expertise in discovery and development, along with an innovative business model to make these technologies broadly accessible to biotechnology and biopharma companies and...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters